Related Experiment Videos
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment
1Neurosciences Unit, Institute of Child Health, Wolfson Centre, London, UK.
Insights
Severe falciparum malaria kills over a million African children annually. Understanding disease mechanisms and developing adjunctive therapies are crucial for improving survival rates in severe malaria cases.
Area of Science:
- Tropical medicine
- Parasitology
- Infectious diseases
Background:
- Severe falciparum malaria remains a leading cause of mortality in African children, with over one million deaths annually.
- Current management strategies have not significantly improved survival rates over the past four decades.
- Understanding the underlying pathophysiological processes is critical for improving outcomes before antimalarial drugs can act.
Purpose of the Study:
- To review potential adjunctive therapies for severe malaria.
- To discuss therapies developed based on detailed clinical and pathophysiological studies.
- To highlight novel approaches for reducing mortality and morbidity in severe malaria.
Main Methods:
- Literature review of clinical and pathophysiological studies on severe malaria.
- Analysis of emerging adjunctive therapies.
- Synthesis of current understanding of severe malaria pathogenesis.
Main Results:
- Several potential adjunctive therapies are under development.
- These therapies target specific pathophysiological pathways contributing to severe malaria.
- Detailed studies are guiding the development of these novel treatments.
Conclusions:
- Adjunctive therapies hold promise for improving survival in severe falciparum malaria.
- Further research into pathophysiological mechanisms is essential for therapeutic development.
- A multi-faceted approach combining antimalarials and adjunctive therapies may be necessary.
Abstract:
Severe falciparum malaria is one of the most lethal parasitic infections in the world and is responsible for more than one million deaths in African children per year. Changes to management over the last 40 years have not improved survival. A reduction in the mortality and morbidity may only come about by a better understanding of the pathophysiological processes that are responsible for severe disease and that determine the outcome before antimalarials have had time to work. This review discusses potential adjunctive therapies for severe malaria that are under development following such detailed clinical and pathophysiological studies.